T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy.
Bettzy StephenJoud HajjarShrutii SardaDzifa Yawa DuoseJeffrey M ConroyCarl MorrisonAnas AlshawaMingxuan XuAbdulrazzak ZarifaSapna Pradyuman PatelYing YuanEvan KwiatkowskiLinghua WangJordi Rodon AhnertSiqing FuFunda Meric-BernstamGeoffrey M LowmanTimothy LooneyAung NaingPublished in: Journal for immunotherapy of cancer (2023)
The data suggest that long-amplicon TCRB repertoire sequencing can potentially identify TRBV haplotype groups that correlate with the risk of severe irAEs. Germline-encoded TRBV polymorphisms may serve as a predictive biomarker of severe irAEs.